Personalised organoid drug treatment and therapy resistance characterization based on novel BRCA2 prostate cancer xenograft of SPOP-like phenotype and microsatellite instability

oleh: S. Karkampouna, F. La Manna, M.R. De Filippo, M. De Menna, E. Zoni, J. Grosjean, I. Klima, A. Garofoli, V. Genitsch, D. Keller, T.H. Booij, C.U. Stirnimann, A. Sboner, C.K.Y. Ng, S. Piscuoglio, M. Spahn, A.R. Mark, G.N. Thalmann, M. Kruithof-De Julio